Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by Mind Medicine Inc.
MindMed to Participate in Upcoming Investor Conferences
November 13, 2024
From
Mind Medicine Inc.
Via
Business Wire
Tickers
MNMD
MindMed Reports Third Quarter 2024 Financial Results and Business Updates
November 07, 2024
From
Mind Medicine Inc.
Via
Business Wire
Tickers
MNMD
MindMed to Host Conference Call and Webcast to Discuss Third Quarter 2024 Financial Results and Provide Business Update
October 24, 2024
From
Mind Medicine Inc.
Via
Business Wire
Tickers
MNMD
MindMed Announces New Employee Inducement Grants
September 09, 2024
From
Mind Medicine Inc.
Via
Business Wire
Tickers
MNMD
MindMed to Participate in September Investor Conferences
September 04, 2024
From
Mind Medicine Inc.
Via
Business Wire
Tickers
MNMD
MindMed Reports Second Quarter 2024 Financial Results and Business Updates
August 13, 2024
From
Mind Medicine Inc.
Via
Business Wire
Tickers
MNMD
MindMed to Present at Canaccord Genuity’s 44th Annual Growth Conference
August 06, 2024
From
Mind Medicine Inc.
Via
Business Wire
Tickers
MNMD
MindMed to Host Conference Call and Webcast to Discuss Second Quarter 2024 Financial Results and Provide Business Update
August 06, 2024
From
Mind Medicine Inc.
Via
Business Wire
Tickers
MNMD
MindMed Appoints Stephanie Fagan as Chief Corporate Affairs Officer
July 29, 2024
From
Mind Medicine Inc.
Via
Business Wire
Tickers
MNMD
MindMed Announces Issuance of New Patent for MM120 Orally Disintegrating Tablet (ODT)
July 17, 2024
From
Mind Medicine Inc.
Via
Business Wire
Tickers
MNMD
MindMed to be Included in Russell 2000® and Russell 3000® Indexes
June 28, 2024
From
Mind Medicine Inc.
Via
Business Wire
Tickers
MNMD
MindMed to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
June 21, 2024
From
Mind Medicine Inc.
Via
Business Wire
Tickers
MNMD
MindMed to Participate in June Conferences
May 28, 2024
From
Mind Medicine Inc.
Via
Business Wire
Tickers
MNMD
MindMed Completes Enrollment of Phase 2a Trial of MM-120 in Adults with Attention-Deficit/Hyperactivity Disorder (ADHD)
October 24, 2023
From
Mind Medicine Inc.
Via
Business Wire
Tickers
MNMD
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.